Straumann Group Connections 2/18

CEO Marco Gadola on Straumann Group 2017 full year results

"Straumann Group Connections" is produced several times per year and puts the spotlight on important topics and events around dentistry and the Straumann Group.

CEO Marco Gadola on Straumann Group 2017 full year results

In 2017, the revenue of the Straumann Group exceeded CHF 1bn, rising 21% (16% organic), while the operating margin expanded to 26%.

Charlotte Stilwell on the Straumann® Novaloc® Retentive System

In this edition of "Straumann Connections", Dr. Charlotte Stilwell talks about the advantages of the Straumann® Novaloc® Retentive System for hybrid dentures which was introduced in the second half of 2016. Being among the first users, she was able to gather a very positive experience with about 10 patients over an observation period of 6 months.

Interview with Mike Rynerson - Head of Straumann's new Digital Business Unit

The Straumann Group has built partnerships with other leading companies in the field of Digital Dentristy including Rapid Shape (3D printing), 3Shape (scanning), and Amann Girrbach (in-lab and chairside mills). To bring them and the Group’s other digital activities closer together and to drive their global expansion, Straumann is creating a global Digital Business Unit under the leadership of Mike Rynerson, who rejoins the Group as a member of the Executive Management Board. With its new set-up, portfolio and partnerships, the Straumann Group is in an excellent position to offer, expand and refine digitally-supported end-to-end solutions for general dentists and specialists.

Straumann et the EAO 2017 in Madrid, Spain

This year, the European Association of Osseointegration celebrated its 25th anniversary and attracted more than four thousand visitors eager to keep up with the latest knowledge and technology. As a diamond sponsor, Straumann used the event to share clinical experience and results, and to showcase its latest solutions.

2017 first-half results: Interview with CEO Marco Gadola

Straumann CEO Marcola Gadola goes briefly through the results first-half 2017 results, with almost 14% of organic growth in the second quarter and all of the sales regions performing double-digit.

Rocking dentistry at the IDS 2017 in Cologne

At the IDS 2017 in Cologne, Straumann has really rocked dentistry. The booth this year featured an innovation cube which took visitors into the future of dentistry in virtual reality. The cube also served as a musical venue that literally rocked the show.

Paul Fugazzotto and Anya Rost creating a 5-day peer-to-peer event on the PURE ceramic implant 

Together with Straumann, Drs. Paul Fugazzotto and Anya Rost partnered with their referring dentists and Dickerman Dental Laboratory to create a 5-day peer-to-peer event in their practice near Boston. Result: A successful event around our Straumann® PURE Ceramic Implant Monotype with highly esthetic results, happy patients and satisfied dentists.

Roxolid®: a new level of confidence

Roxolid® has brought a new level of confidence to implant dentistry that enables Straumann to offer an industry leading guarantee. In this issue of “Straumann Connections”, Frank Hemm, Executive Vice President and Head of Customer Solutions & Education at Straumann, explains why Straumann has taken this decision and what it means for surgeons and patients.

4-day surgical event with 22 patients in Warsaw

March 2016: together with our Polish Distributor, Schmidtdental (, Straumann set up a 4-day surgical event with 22 patients (27 edentulous jaw cases) in Warsaw. Lead by Dr. Krzysztof Chmielewski, 15 selected clinicians took part in this event, which put to the test of daily practice the Straumann® Bone Level Tapered Implant (BLT) in combination with Straumann® Guided Surgery (now BLT-ready) and the Straumann® Pro Arch solution. One of the key goals was to provide these top surgeons with a unique clinical experience to fully convince them of the Straumann solutions.

Excellent results for Straumann in independent peri-implantitis study

Excellent results for Straumann in independent peri-implantitis study: in a large retrospective study of dental implants in a broad clinical setting (427 patients, 1578 implants from various manufacturers, 9-year follow-up),  significantly lower odds ratios for moderate/severe peri-implantitis with Straumann Tissue Level SLA implants than with the other implant systems were evaluated. The study published in the peer-reviewed Journal of Dental Research Findings is highly relevant for dentists who base their choice of implant on independent clinical evidence.